Systemic tumor-cell reprogramming converts solid tumors into in situ biofactories for immunotherapy
Shihui Wang, Qing Xu, Mengyao Wu, Jiarong Duan, Qin Gao, Haimin Ma, Wei Li, Tianqing Zheng
LENTRA reprograms tumor cells to produce therapeutic molecules, inducing antitumor immunity and durable immune memory in mouse models and patient-derived explants.
bioRxiv · Sep 28, 2026 · PreprintCancer Biology